The Health Extension Foundation Presents:
Prof. Judith Campisi – Co-Founder of Unity Biotech
Come listen to Professor Judith Campisi talk about her research and co-founding Unity biotechnology, a uniquely successful health extension start up.
A special 10 minute talk on Tissue Damage and Aging will also be given by Harshi Peiris who recently won the Hillblom award.
UNITY Biotechnology designs therapeutics that prevent, halt, or reverse diseases of aging. UNITY has demonstrated in animal models that selectively eliminating senescent cells reverses or prevents a wide range of diseases, including osteoarthritis, atherosclerosis, eye diseases, and kidney diseases. Listen to Prof Judith Campisi talk about these exciting developments and more!
Prof. Campisi’s research integrates the genetic, environmental and evolutionary forces that result in age-related diseases, and identifies potential therapeutic targets that can be modified to mitigate basic aging processes. Judy began her career by studying the causes of cancer. She soon realized that aging is the largest risk factor for developing this disease and that cellular senescence – which evolved to prevent cancer in young organisms – was an important contributor to late-life cancer. She is widely recognized for her work on senescent cells and their influence on many manifestations of aging. Her laboratory discovered the first biomarker for senescence, which she used to identify senescent cells in human and rodent tissues and to show that these cells increase in number with age. Her laboratory also discovered that senescent cells can cause inflammation, which disrupts normal tissue function and, ironically, drives the progression of cancer.
The event is hosted at the Buck Institute for Research on Aging, an I.M. Pei designed facility, located on Mt. Burdell in Novato.